{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:17:23Z","timestamp":1776334643621,"version":"3.51.2"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.transproceed.2020.02.019","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T17:16:22Z","timestamp":1585847782000},"page":"1132-1135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analyses of Programmed Cell Death Protein 1 in High Immunologic-Risk Transplant Patients"],"prefix":"10.1016","volume":"52","author":[{"given":"M.A.","family":"Carmona-Escamilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Fonseca-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica-L.Prieto","family":"Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes Arriga","family":"Pizando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virgilia","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia Alejandra","family":"Hern\u00e1ndez-Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Garc\u00eda-Covarrubias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Queipo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2020.02.019_bib1","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(11)60699-5","article-title":"Diagnosis and prevention of chronic kidney allograft loss","volume":"378","author":"Nankivell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2020.02.019_bib2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00120-016-0205-3","article-title":"Die Geschichte der Nierentransplantation [The history of kidney transplantation","volume":"55","author":"Hatzinger","year":"2016","journal-title":"Urologe A"},{"key":"10.1016\/j.transproceed.2020.02.019_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.trre.2012.07.002","article-title":"Chronic renal allograft injury: early detection, accurate diagnosis and management","volume":"26","author":"Pascual","year":"2012","journal-title":"Transplant Rev"},{"key":"10.1016\/j.transproceed.2020.02.019_bib4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.02.019_bib5","unstructured":"Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. (A. Abul K., Ed.) (8th edItion). 2014. Retrieved from 978-0323222754."},{"key":"10.1016\/j.transproceed.2020.02.019_bib6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.transproceed.2020.02.019_bib7","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2215\/CJN.01750218","article-title":"Regulatory T cells and kidney transplantation","volume":"13","author":"Martin-Moreno","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2020.02.019_bib8","first-page":"341","article-title":"Safe administration of an anti-PD-1 antibody to kidney-transplant patients: 2 clinical cases and review of the literature","volume":"40","author":"Winkler","year":"2017","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.transproceed.2020.02.019_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092194","article-title":"Programmed cell death 1 (PD-1) inhibitors in renal transplant patients with advanced cancer: a double-edged sword?","volume":"20","author":"Lai","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.transproceed.2020.02.019_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2020.02.019_bib11","first-page":"7452019","article-title":"Kidney transplant outcome is associated with regulatory T cell population and gene expression early after transplantation","volume":"2019","author":"Krajewska","year":"2019","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.transproceed.2020.02.019_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.intimp.2018.10.028","article-title":"International immunopharmacology the number of fox P3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: a multistage systematic review","volume":"65","author":"Herrera-G\u00f3mez","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.transproceed.2020.02.019_bib13","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/eji.200737583","article-title":"Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519317610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519317610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:33:57Z","timestamp":1758576837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519317610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0041134519317610"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.02.019","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analyses of Programmed Cell Death Protein 1 in High Immunologic-Risk Transplant Patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2020.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}